Can treatment started with the Bowmed Ibisqus Limited co-amoxiclav 1000 mg/200 mg injection or infusion product be completed with an appropriate oral formulation?

Yes, treatment initiated intravenously with the Bowmed Ibisqus Limited co-amoxiclav 1000 mg/200 mg injection or infusion product may be completed with an appropriate oral formulation, as considered appropriate for the individual patient.